LRRK2 activation in idiopathic Parkinson’s disease
2018; American Association for the Advancement of Science; Volume: 10; Issue: 451 Linguagem: Inglês
10.1126/scitranslmed.aar5429
ISSN1946-6242
AutoresRoberto Di Maio, Eric K. Hoffman, Emily M. Rocha, Matthew T. Keeney, Laurie H. Sanders, Briana R. De Miranda, Alevtina Zharikov, Amber D. Van Laar, Antonia F. Stepan, Thomas A. Lanz, Julia Kofler, Edward A. Burton, Dario R. Alessi, Teresa G. Hastings, J. Timothy Greenamyre,
Tópico(s)Botulinum Toxin and Related Neurological Disorders
ResumoWild-type LRRK2 is activated in nigrostriatal dopamine neurons in idiopathic Parkinson’s disease and plays a pathogenic role in this neurodegenerative disorder.
Referência(s)